Welcome to LiVDerm
Where the Constellations of Medical Dermatology and Aesthetics Collide
Led by world-renowned experts in the field, LiVDerm is a comprehensive dermatologic hub where medical professionals educate, collaborate, and engage.
LiVDerm’s mission is to boldly advance higher standards of dermatology care through live and virtual educational offerings, resources for providers, students and patients, and much more.
As a leading source for the latest therapies, technologies, procedures, and practice guidelines in medical and aesthetic dermatology, LiVDerm empowers providers to manage dermatologic conditions with confident authority. With a multipronged focus on the myriad specialties within the field, LiVDerm provides innovative and integrated education across the dermatology spectrum.
Upcoming Live Events
Complimentary Continuing Education
Enduring Webcast
Expanding the Therapeutic “AHR”senal for Pediatric Atopic Dermatitis
Enduring Webcast
Advances in Non-Steroidal Topicals: PDE-4 Inhibitors for Seborrheic Dermatitis and Beyond
Deep Dive
The Gut-Skin Connection: The Microbiome and Its Effects on the Skin
LivDerm Articles
Study Highlights Safety and Efficacy of Monopolar Radiofrequency and HIFES in Patients Receiving Botulinum ToxinÂ
FDA Approves BIMZELX for Moderate-to-Severe Hidradenitis SuppurativaÂ
New Protection and Repair Skincare Regimen Improves Photoaging Â
Study Evaluates Relationship Between Hidradenitis Suppurativa and Precocious Puberty
FDA Grants Rare Pediatric Disease Designation for BPGbio’s BPM31510T for EBÂ
Study Finds Newly Diagnosed Alopecia Areata Linked to Increased Risk of Psychiatric and Autoimmune ConditionsÂ
FDA Approves BOTOX® Cosmetic for Platysma Bands in Adults
Topical Corticosteroid Phobia is Prevalent Among Patients with Chronic Hand EczemaÂ
Study Underway to Evaluate Rezpegaldesleukin (REZPEG) for the Treatment of Alopecia AreataÂ
Semaglutide Demonstrates Potential in Improving Outcomes for Hidradenitis Suppurativa in Patients with ObesityÂ
Arcutis Announces FDA has Accepted its Supplemental New Drug Application for ZORYVE® (roflumilast) FoamÂ
Eli Lilly’s EBGLYSS Receives FDA Approval for Patients 12 and Above with Moderate-to-Severe Atopic DermatitisÂ
AHEAD Recommendations for Atopic Dermatitis
National Psoriasis Foundation Publishes Psoriasis Health Indicator ReportÂ
FDA Warns Consumers Against Using Chemical Peel Products Without Professional ConsultationÂ
FDA Approves Galderma’s Nemluvio® (nemolizumab) for Prurigo Nodularis in AdultsÂ
Skin Deep: Dr. Zoe Diana Draelos Explores Ethnic Variations in Skin Physiology - Dermatology Times ExclusiveÂ
Omega-3 Fatty Acid Supplementation May Help Alleviate Acne Severity Â
FDA Approves LEQSELVI (deuruxolitinib) for Severe Alopecia Areata in AdultsÂ
Crystal Structure Analysis Supports Bimekizumab's IL-17 Dual InhibitionÂ
LivDerm Podcasts
IL 31 Mechanism of Action and Clinical Implications for Prurigo Nodularis
Achieving More: How and When to Switch Systemic Therapies in Atopic Dermatitis?
Exploring the Latest Updates in the Epidermolysis Bullosa Treatment Landscape
Exposing the Epidermolysis Bullosa Patient Burden and Challenges in Disease Management
All Hands on Deck: Distinguishing Chronic Hand Eczema
Examining the Gaps and Challenges in Diagnosing and Treating Prurigo Nodularis
Skirting Steroids in Atopic Dermatitis: New Therapies and Expert Strategies for Long-term Control
Choosing the Right Path: JAK Inhibitors or Biologics for Atopic Dermatitis?
Skirting Steroids in Atopic Dermatitis: Dangers and Side Effects of Steroid Exposure in Treatment of AD
Setting the Stage: Effective Onboarding of your AD Patients onto JAK Inhibitor Therapy
The Quest for Itch-Free, Clear Skin in Atopic Dermatitis: New Practice-Informing Evidence
Targeted Intervention for Hidradenitis Suppurativa: Defining Window of Opportunity for Moderate-to-Severe Patients
JAK Inhibitors in Action: Effectiveness in Atopic Dermatitis
Psoriasis in Skin of Color Unplugged: Patient and Disease Advocacy
Psoriasis in Skin of Color Unplugged: Advancing Diversity and Inclusion in Clinical Trials
Psoriasis in Skin of Color Unplugged: Gaps in Diagnosis and Dermatologist Training
Psoriasis in Skin of Color Unplugged: Disparities and Access to Care
The Spectrum of Atopic Dermatitis and the Emerging Role of JAK Inhibitors
Eczema Awareness Month with Dr Bunick
Eczema Awareness Month with Dr. Lio
Updates in JAK Inhibitor Therapies for Alopecia Areata with Brett King, MD
Nuanced Treatment of Pediatric Alopecia Areata with Brittany Craiglow, MD
Navigating the Expanding Treatment Landscape for Pediatric Patients with Atopic Dermatitis
Pearls for Early and Accurate Diagnosis of Infantile Atopic Dermatitis
Improving Communication and Shared Decision-Making with Caregivers of Patients with Atopic Dermatitis
Deeper than the Surface of Skin
The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis
The New Kids on the Block: IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis
Dermatologic Care in the Sexual and Gender Diverse Patient with Klint Peebles, MD
The Latest Advances in Cosmetic Dermatology with Doris J. Day, MD
Redefining Perfection, with Jason J. Emer, MD
The Latest Advances with Energy-Based Devices and Scar Treatments with Michael H. Gold, MD, FAAD
Anatomy Matters: The Cadaver Lab Experience with Z. Paul Lorenc, MD
Skin Cancer Prevention and Latest Advancements in Dermatology
Live Patient Injections for Skin Rejuvenation
Finding the Fountain of Youth: How Light Keeps Your Skin Glowing
Science is your guide. Anatomy is your savior
Dermatology, Longevity, and Overall Health
The Latest Developments in Dermatology
Emerging Treatments in Dermatology
Treating Atopic Dermatitis in Pediatric Patients
Connect With Us
Looking for more information on our educational opportunities? Please fill out the form below to be contacted by one of our education advisors.